NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Paradeep Phosphates Research Report

Initiation of Coverage: Accumulate Rating

We initiate coverage on Paradeep Phosphates Ltd. (PPL) with an Accumulate rating and a target price of INR120, based on 10x FY28E EPS. The company is poised to capitalize on the import substitution opportunity in India's chemicals sector through backward integration, product mix optimization, and capacity expansion.

Key Initiatives

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

  • Capacity Expansion: PPL is expanding its phosphoric and sulfuric acid capacities by 57% and 100%, respectively, to achieve full backward integration by FY29.
  • Product Mix Optimization: The company is shifting its portfolio towards high-value complex fertilizers, reducing reliance on DAP.
  • Capacity Addition: PPL is expanding its fertilizer capacity to reach approximately 5.0 mmtpa by early FY29.
  • Mergers and Acquisitions: The MCFL merger will strengthen PPL's presence in South India.

Outlook and Financial Projections

We estimate revenue/EBITDA/PAT CAGR of ~10%/18%/23% over FY25-28E, driven by capacity additions, product mix improvement, and integration benefits. At current market price, PPL trades at ~9x FY28E EPS and ~6x FY28E EV/EBITDA.

Valuation

Read also: Suzlon to Expand Business Scope Beyond Wind Energy, Invests Rs 500 Crore in New Subsidiary This Fiscal Year

  • Price to Earnings (P/E) Ratio: 9x FY28E EPS
  • Enterprise Value to EBITDA (EV/EBITDA) Ratio: 6x FY28E EV/EBITDA

Investor Takeaway

Investors should consider accumulating Paradeep Phosphates due to its potential for sustained earnings growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.